risks of malignancies due to ibd and immunomodulators and/or biologic therapy
Published 8 years ago • 426 plays • Length 21:04Download video MP4
Download video MP3
Similar videos
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
21:14
when and how to use immunomodulators and biologics in ibd
-
18:39
what are the skin side effects due to immunomodulators and/or biologics?
-
18:22
other major side effects due to immunomodulators and/or biologics in our ibd patients
-
18:02
perspectives on immunomodulators and biologics: risk of neoplasia and malignancy development
-
19:03
debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
-
6:29
understanding the risks and benefits of ibd therapies
-
19:37
how often do immunomodulators and/or biologics cause lymphoma and/or cancer, and can we prevent it?
-
11:32
debate: ibd patient on biologic or immunomodulator who develops a malignancy - must stop these meds
-
21:18
how can we prevent and manage the common side effects of immunomodulators and biologics?
-
24:47
diagnosis and management of infections in ibd patients on immunomodulators and biologics
-
21:09
infections due to immunomodulators and/or biologics: identification, prevention and treatment
-
18:43
neurologic, rheumatologic, and optic complications related to immunomodulators and biologic
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
22:19
vaccinations and ibd patients: what, when, and why?
-
33:34
optimizing the efficacy of immunomodulators and biologics in pediatric ibd
-
8:17
biologics and inflammatory bowel disease
-
29:01
advances in ibd treatment: expert q&a